Global Recombinant Human Anti-RSV Antibody(AM14) Market Growth 2026-2032

September 2026 | 82 pages | ID: G08BFB1E28C0EN
LP Information

Abstracts

The global Recombinant Human Anti-RSV Antibody(AM14) market size is predicted to grow from US$ 36.88 million in 2025 to US$ 69.45 million in 2032; it is expected to grow at a CAGR of 9.6% from 2026 to 2032.

United States market for Recombinant Human Anti-RSV Antibody(AM14) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Recombinant Human Anti-RSV Antibody(AM14) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Recombinant Human Anti-RSV Antibody(AM14) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Recombinant Human Anti-RSV Antibody(AM14) players cover Creative Biolabs, Cambridge Biologics, Leading Biology, Biovision, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Recombinant Human Anti-RSV Antibody(AM14) Industry Forecast” looks at past sales and reviews total world Recombinant Human Anti-RSV Antibody(AM14) sales in 2025, providing a comprehensive analysis by region and market sector of projected Recombinant Human Anti-RSV Antibody(AM14) sales for 2026 through 2032. With Recombinant Human Anti-RSV Antibody(AM14) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Human Anti-RSV Antibody(AM14) industry.

This Insight Report provides a comprehensive analysis of the global Recombinant Human Anti-RSV Antibody(AM14) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Human Anti-RSV Antibody(AM14) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Human Anti-RSV Antibody(AM14) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Human Anti-RSV Antibody(AM14) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Human Anti-RSV Antibody(AM14).

This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Human Anti-RSV Antibody(AM14) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• >90%
• >95%
• >98%
• Others

Segmentation by Application:

• ELISA
• WB
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Creative Biolabs
• Cambridge Biologics
• Leading Biology
• Biovision

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Recombinant Human Anti-RSV Antibody(AM14) market?
• What factors are driving Recombinant Human Anti-RSV Antibody(AM14) market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Recombinant Human Anti-RSV Antibody(AM14) market opportunities vary by end market size?
• How does Recombinant Human Anti-RSV Antibody(AM14) break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Recombinant Human Anti-RSV Antibody(AM14) Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Recombinant Human Anti-RSV Antibody(AM14) by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Recombinant Human Anti-RSV Antibody(AM14) by Country/Region, 2021, 2025 & 2032
2.2 Recombinant Human Anti-RSV Antibody(AM14) Segment by Type
  2.2.1 >90%
  2.2.2 >95%
  2.2.3 >98%
  2.2.4 Others
  2.2.5 Recombinant Human Anti-RSV Antibody(AM14) Sales by Type
    2.2.5.1 Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Type (2021-2026)
    2.2.5.2 Global Recombinant Human Anti-RSV Antibody(AM14) Revenue and Market Share by Type (2021-2026)
    2.2.5.3 Global Recombinant Human Anti-RSV Antibody(AM14) Sale Price by Type (2021-2026)
2.3 Recombinant Human Anti-RSV Antibody(AM14) Segment by Application
  2.3.1 ELISA
  2.3.2 WB
  2.3.3 Others
  2.3.4 Recombinant Human Anti-RSV Antibody(AM14) Sales by Application
    2.3.4.1 Global Recombinant Human Anti-RSV Antibody(AM14) Sale Market Share by Application (2021-2026)
    2.3.4.2 Global Recombinant Human Anti-RSV Antibody(AM14) Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global Recombinant Human Anti-RSV Antibody(AM14) Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Recombinant Human Anti-RSV Antibody(AM14) Breakdown Data by Company
  3.1.1 Global Recombinant Human Anti-RSV Antibody(AM14) Annual Sales by Company (2021-2026)
  3.1.2 Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Company (2021-2026)
3.2 Global Recombinant Human Anti-RSV Antibody(AM14) Annual Revenue by Company (2021-2026)
  3.2.1 Global Recombinant Human Anti-RSV Antibody(AM14) Revenue by Company (2021-2026)
  3.2.2 Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Company (2021-2026)
3.3 Global Recombinant Human Anti-RSV Antibody(AM14) Sale Price by Company
3.4 Key Manufacturers Recombinant Human Anti-RSV Antibody(AM14) Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Recombinant Human Anti-RSV Antibody(AM14) Product Location Distribution
  3.4.2 Players Recombinant Human Anti-RSV Antibody(AM14) Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR RECOMBINANT HUMAN ANTI-RSV ANTIBODY(AM14) BY GEOGRAPHIC REGION

4.1 World Historic Recombinant Human Anti-RSV Antibody(AM14) Market Size by Geographic Region (2021-2026)
  4.1.1 Global Recombinant Human Anti-RSV Antibody(AM14) Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Recombinant Human Anti-RSV Antibody(AM14) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Recombinant Human Anti-RSV Antibody(AM14) Market Size by Country/Region (2021-2026)
  4.2.1 Global Recombinant Human Anti-RSV Antibody(AM14) Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Recombinant Human Anti-RSV Antibody(AM14) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Recombinant Human Anti-RSV Antibody(AM14) Sales Growth
4.4 APAC Recombinant Human Anti-RSV Antibody(AM14) Sales Growth
4.5 Europe Recombinant Human Anti-RSV Antibody(AM14) Sales Growth
4.6 Middle East & Africa Recombinant Human Anti-RSV Antibody(AM14) Sales Growth

5 AMERICAS

5.1 Americas Recombinant Human Anti-RSV Antibody(AM14) Sales by Country
  5.1.1 Americas Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2021-2026)
  5.1.2 Americas Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2021-2026)
5.2 Americas Recombinant Human Anti-RSV Antibody(AM14) Sales by Type (2021-2026)
5.3 Americas Recombinant Human Anti-RSV Antibody(AM14) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Recombinant Human Anti-RSV Antibody(AM14) Sales by Region
  6.1.1 APAC Recombinant Human Anti-RSV Antibody(AM14) Sales by Region (2021-2026)
  6.1.2 APAC Recombinant Human Anti-RSV Antibody(AM14) Revenue by Region (2021-2026)
6.2 APAC Recombinant Human Anti-RSV Antibody(AM14) Sales by Type (2021-2026)
6.3 APAC Recombinant Human Anti-RSV Antibody(AM14) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Recombinant Human Anti-RSV Antibody(AM14) by Country
  7.1.1 Europe Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2021-2026)
  7.1.2 Europe Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2021-2026)
7.2 Europe Recombinant Human Anti-RSV Antibody(AM14) Sales by Type (2021-2026)
7.3 Europe Recombinant Human Anti-RSV Antibody(AM14) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Recombinant Human Anti-RSV Antibody(AM14) by Country
  8.1.1 Middle East & Africa Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2021-2026)
8.2 Middle East & Africa Recombinant Human Anti-RSV Antibody(AM14) Sales by Type (2021-2026)
8.3 Middle East & Africa Recombinant Human Anti-RSV Antibody(AM14) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Human Anti-RSV Antibody(AM14)
10.3 Manufacturing Process Analysis of Recombinant Human Anti-RSV Antibody(AM14)
10.4 Industry Chain Structure of Recombinant Human Anti-RSV Antibody(AM14)

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Recombinant Human Anti-RSV Antibody(AM14) Distributors
11.3 Recombinant Human Anti-RSV Antibody(AM14) Customer

12 WORLD FORECAST REVIEW FOR RECOMBINANT HUMAN ANTI-RSV ANTIBODY(AM14) BY GEOGRAPHIC REGION

12.1 Global Recombinant Human Anti-RSV Antibody(AM14) Market Size Forecast by Region
  12.1.1 Global Recombinant Human Anti-RSV Antibody(AM14) Forecast by Region (2027-2032)
  12.1.2 Global Recombinant Human Anti-RSV Antibody(AM14) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Recombinant Human Anti-RSV Antibody(AM14) Forecast by Type (2027-2032)
12.7 Global Recombinant Human Anti-RSV Antibody(AM14) Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Creative Biolabs
  13.1.1 Creative Biolabs Company Information
  13.1.2 Creative Biolabs Recombinant Human Anti-RSV Antibody(AM14) Product Portfolios and Specifications
  13.1.3 Creative Biolabs Recombinant Human Anti-RSV Antibody(AM14) Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Creative Biolabs Main Business Overview
  13.1.5 Creative Biolabs Latest Developments
13.2 Cambridge Biologics
  13.2.1 Cambridge Biologics Company Information
  13.2.2 Cambridge Biologics Recombinant Human Anti-RSV Antibody(AM14) Product Portfolios and Specifications
  13.2.3 Cambridge Biologics Recombinant Human Anti-RSV Antibody(AM14) Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Cambridge Biologics Main Business Overview
  13.2.5 Cambridge Biologics Latest Developments
13.3 Leading Biology
  13.3.1 Leading Biology Company Information
  13.3.2 Leading Biology Recombinant Human Anti-RSV Antibody(AM14) Product Portfolios and Specifications
  13.3.3 Leading Biology Recombinant Human Anti-RSV Antibody(AM14) Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Leading Biology Main Business Overview
  13.3.5 Leading Biology Latest Developments
13.4 Biovision
  13.4.1 Biovision Company Information
  13.4.2 Biovision Recombinant Human Anti-RSV Antibody(AM14) Product Portfolios and Specifications
  13.4.3 Biovision Recombinant Human Anti-RSV Antibody(AM14) Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Biovision Main Business Overview
  13.4.5 Biovision Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Recombinant Human Anti-RSV Antibody(AM14) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Recombinant Human Anti-RSV Antibody(AM14) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of >90%
Table 4. Major Players of >95%
Table 5. Major Players of >98%
Table 6. Major Players of Others
Table 7. Global Recombinant Human Anti-RSV Antibody(AM14) Sales by Type (2021-2026) & (K Units)
Table 8. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Type (2021-2026)
Table 9. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue by Type (2021-2026) & ($ million)
Table 10. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Type (2021-2026)
Table 11. Global Recombinant Human Anti-RSV Antibody(AM14) Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Recombinant Human Anti-RSV Antibody(AM14) Sale by Application (2021-2026) & (K Units)
Table 13. Global Recombinant Human Anti-RSV Antibody(AM14) Sale Market Share by Application (2021-2026)
Table 14. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue by Application (2021-2026) & ($ million)
Table 15. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Application (2021-2026)
Table 16. Global Recombinant Human Anti-RSV Antibody(AM14) Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Recombinant Human Anti-RSV Antibody(AM14) Sales by Company (2021-2026) & (K Units)
Table 18. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Company (2021-2026)
Table 19. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Company (2021-2026)
Table 21. Global Recombinant Human Anti-RSV Antibody(AM14) Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Recombinant Human Anti-RSV Antibody(AM14) Producing Area Distribution and Sales Area
Table 23. Players Recombinant Human Anti-RSV Antibody(AM14) Products Offered
Table 24. Recombinant Human Anti-RSV Antibody(AM14) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Recombinant Human Anti-RSV Antibody(AM14) Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share Geographic Region (2021-2026)
Table 29. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Recombinant Human Anti-RSV Antibody(AM14) Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Country/Region (2021-2026)
Table 33. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2021-2026) & (K Units)
Table 36. Americas Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Country (2021-2026)
Table 37. Americas Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Recombinant Human Anti-RSV Antibody(AM14) Sales by Type (2021-2026) & (K Units)
Table 39. Americas Recombinant Human Anti-RSV Antibody(AM14) Sales by Application (2021-2026) & (K Units)
Table 40. APAC Recombinant Human Anti-RSV Antibody(AM14) Sales by Region (2021-2026) & (K Units)
Table 41. APAC Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Region (2021-2026)
Table 42. APAC Recombinant Human Anti-RSV Antibody(AM14) Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Recombinant Human Anti-RSV Antibody(AM14) Sales by Type (2021-2026) & (K Units)
Table 44. APAC Recombinant Human Anti-RSV Antibody(AM14) Sales by Application (2021-2026) & (K Units)
Table 45. Europe Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2021-2026) & (K Units)
Table 46. Europe Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Recombinant Human Anti-RSV Antibody(AM14) Sales by Type (2021-2026) & (K Units)
Table 48. Europe Recombinant Human Anti-RSV Antibody(AM14) Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Recombinant Human Anti-RSV Antibody(AM14) Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Recombinant Human Anti-RSV Antibody(AM14) Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Recombinant Human Anti-RSV Antibody(AM14)
Table 54. Key Market Challenges & Risks of Recombinant Human Anti-RSV Antibody(AM14)
Table 55. Key Industry Trends of Recombinant Human Anti-RSV Antibody(AM14)
Table 56. Recombinant Human Anti-RSV Antibody(AM14) Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Recombinant Human Anti-RSV Antibody(AM14) Distributors List
Table 59. Recombinant Human Anti-RSV Antibody(AM14) Customer List
Table 60. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Recombinant Human Anti-RSV Antibody(AM14) Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Recombinant Human Anti-RSV Antibody(AM14) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Recombinant Human Anti-RSV Antibody(AM14) Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Recombinant Human Anti-RSV Antibody(AM14) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Recombinant Human Anti-RSV Antibody(AM14) Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Recombinant Human Anti-RSV Antibody(AM14) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Recombinant Human Anti-RSV Antibody(AM14) Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Recombinant Human Anti-RSV Antibody(AM14) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Creative Biolabs Basic Information, Recombinant Human Anti-RSV Antibody(AM14) Manufacturing Base, Sales Area and Its Competitors
Table 75. Creative Biolabs Recombinant Human Anti-RSV Antibody(AM14) Product Portfolios and Specifications
Table 76. Creative Biolabs Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Creative Biolabs Main Business
Table 78. Creative Biolabs Latest Developments
Table 79. Cambridge Biologics Basic Information, Recombinant Human Anti-RSV Antibody(AM14) Manufacturing Base, Sales Area and Its Competitors
Table 80. Cambridge Biologics Recombinant Human Anti-RSV Antibody(AM14) Product Portfolios and Specifications
Table 81. Cambridge Biologics Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Cambridge Biologics Main Business
Table 83. Cambridge Biologics Latest Developments
Table 84. Leading Biology Basic Information, Recombinant Human Anti-RSV Antibody(AM14) Manufacturing Base, Sales Area and Its Competitors
Table 85. Leading Biology Recombinant Human Anti-RSV Antibody(AM14) Product Portfolios and Specifications
Table 86. Leading Biology Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Leading Biology Main Business
Table 88. Leading Biology Latest Developments
Table 89. Biovision Basic Information, Recombinant Human Anti-RSV Antibody(AM14) Manufacturing Base, Sales Area and Its Competitors
Table 90. Biovision Recombinant Human Anti-RSV Antibody(AM14) Product Portfolios and Specifications
Table 91. Biovision Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Biovision Main Business
Table 93. Biovision Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Recombinant Human Anti-RSV Antibody(AM14)
Figure 2. Recombinant Human Anti-RSV Antibody(AM14) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Recombinant Human Anti-RSV Antibody(AM14) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Country/Region (2025)
Figure 10. Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of >90%
Figure 12. Product Picture of >95%
Figure 13. Product Picture of >98%
Figure 14. Product Picture of Others
Figure 15. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Type in 2026
Figure 16. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Type (2021-2026)
Figure 17. Recombinant Human Anti-RSV Antibody(AM14) Consumed in ELISA
Figure 18. Global Recombinant Human Anti-RSV Antibody(AM14) Market: ELISA (2021-2026) & (K Units)
Figure 19. Recombinant Human Anti-RSV Antibody(AM14) Consumed in WB
Figure 20. Global Recombinant Human Anti-RSV Antibody(AM14) Market: WB (2021-2026) & (K Units)
Figure 21. Recombinant Human Anti-RSV Antibody(AM14) Consumed in Others
Figure 22. Global Recombinant Human Anti-RSV Antibody(AM14) Market: Others (2021-2026) & (K Units)
Figure 23. Global Recombinant Human Anti-RSV Antibody(AM14) Sale Market Share by Application (2025)
Figure 24. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Application in 2026
Figure 25. Recombinant Human Anti-RSV Antibody(AM14) Sales by Company in 2026 (K Units)
Figure 26. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Company in 2026
Figure 27. Recombinant Human Anti-RSV Antibody(AM14) Revenue by Company in 2026 ($ millions)
Figure 28. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Company in 2026
Figure 29. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Recombinant Human Anti-RSV Antibody(AM14) Sales 2021-2026 (K Units)
Figure 32. Americas Recombinant Human Anti-RSV Antibody(AM14) Revenue 2021-2026 ($ millions)
Figure 33. APAC Recombinant Human Anti-RSV Antibody(AM14) Sales 2021-2026 (K Units)
Figure 34. APAC Recombinant Human Anti-RSV Antibody(AM14) Revenue 2021-2026 ($ millions)
Figure 35. Europe Recombinant Human Anti-RSV Antibody(AM14) Sales 2021-2026 (K Units)
Figure 36. Europe Recombinant Human Anti-RSV Antibody(AM14) Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Recombinant Human Anti-RSV Antibody(AM14) Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Recombinant Human Anti-RSV Antibody(AM14) Revenue 2021-2026 ($ millions)
Figure 39. Americas Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Country in 2026
Figure 40. Americas Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Country (2021-2026)
Figure 41. Americas Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Type (2021-2026)
Figure 42. Americas Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Application (2021-2026)
Figure 43. United States Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Region in 2026
Figure 48. APAC Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Region (2021-2026)
Figure 49. APAC Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Type (2021-2026)
Figure 50. APAC Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Application (2021-2026)
Figure 51. China Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 55. India Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Country in 2026
Figure 59. Europe Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Country (2021-2026)
Figure 60. Europe Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Type (2021-2026)
Figure 61. Europe Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Application (2021-2026)
Figure 62. Germany Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 63. France Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Application (2021-2026)
Figure 70. Egypt Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Recombinant Human Anti-RSV Antibody(AM14) in 2026
Figure 76. Manufacturing Process Analysis of Recombinant Human Anti-RSV Antibody(AM14)
Figure 77. Industry Chain Structure of Recombinant Human Anti-RSV Antibody(AM14)
Figure 78. Channels of Distribution
Figure 79. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Forecast by Region (2027-2032)
Figure 80. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share Forecast by Application (2027-2032)